Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities

por Lemech, Charlotte, Arkenau, Hendrik-Tobias
Publicado 2012

Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice

por Lemech, Charlotte, Arkenau, Hendrik-Tobias
Publicado 2011

Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence

por Voskoboynik, Mark, Arkenau, Hendrik-Tobias
Publicado 2014

Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

por Fontana, Elisa, Arkenau, Hendrik-Tobias
Publicado 2020

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

por Mak, Gabriel, Arkenau, Hendrik-Tobias, Chin, Melvin
Publicado 2014

Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies

por Shih, Kent, Arkenau, Hendrik-Tobias, Infante, Jeffrey R.
Publicado 2014

Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma

por Fostea, Raluca Maria, Fontana, Elisa, Torga, Gonzalo, Arkenau, Hendrik-Tobias
Publicado 2020

Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations

por Saggese, Matilde, Dua, Divyanshu, Simmons, Emily, Lemech, Charlotte, Arkenau, Hendrik-Tobias
Publicado 2013

Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer

por Moschetta, Michele, Mak, Gabriel, Hauser, Joana, Davies, Catriona, Uccello, Mario, Arkenau, Hendrik-Tobias
Publicado 2017

Signal pathways and precision therapy of small-cell lung cancer

por Yuan, Min, Zhao, Yu, Arkenau, Hendrik-Tobias, Lao, Tongnei, Chu, Li, Xu, Qing
Publicado 2022

Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey

por Brunetto, Andre, Olmos, David, Arkenau, Hendrik-Tobias, Tan, Daniel, Yap, Timomy, de Bono, Johann, Barriuso, Jorge, Kaye, Stan
Publicado 2011

Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

por Moschetta, Michele, Uccello, Mario, Kasenda, Benjamin, Mak, Gabriel, McClelland, Anissa, Boussios, Stergios, Forster, Martin, Arkenau, Hendrik-Tobias
Publicado 2017

Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

por Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer
Publicado 2016

Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

por Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer
Publicado 2016

Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

por Laille, Eric, Patel, Manish, Jones, Suzanne F., Burris, Howard A., Infante, Jeffrey, Lemech, Charlotte, Liu, Liangang, Arkenau, Hendrik‐Tobias
Publicado 2015

Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors

por Perry, Nick, Moss, Sue, Dixon, Steve, Milner, Sue, Mokbel, Kefah, Lemech, Charlotte, Arkenau, Hendrik-Tobias, Duffy, Stephen, Pinker, Katja
Publicado 2020

Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors

por Bendell, Johanna C., Patel, Manish R., Moore, Kathleen N., Chua, Cynthia C., Arkenau, Hendrik‐Tobias, Dukart, Gary, Harrow, Kim, Liang, Chris
Publicado 2018

Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping

por Morelli, Cristina, Formica, Vincenzo, Doldo, Elena, Riondino, Silvia, Rofei, Michela, Vergilii, Lorena, Palmieri, Giampiero, Arkenau, Hendrik-Tobias, Roselli, Mario, Orlandi, Augusto
Publicado 2022

Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors

por Bendell, Johanna C., Patel, Manish R., Yoshida, Kenichiro, Seraj, Jabed, Weaver, Racquel, Lemech, Charlotte, Todaro, Thomas G., Pant, Shubham, Arkenau, Hendrik-Tobias
Publicado 2016

Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors

por Arkenau, Hendrik‐Tobias, Taylor, Donatienne, Xu, Xiaoying, Chitnis, Shripad, Llacer‐Perez, Casilda, Moore, Kathleen, Nidamarthy, Prasanna Kumar, Ilankumaran, Palanichamy, De Vos‐Geelen, Judith
Publicado 2022